Michael J. Morris, MD

Videos

Results of phase 3 CONDOR study could have a far-reaching impact on patients with prostate cancer.

Michael J. Morris, MD, on Future Directions of PSMA Imaging in Prostate Cancer 

Articles

An analysis of the secondary endpoint of the phase III CONDOR study showed PSMA scans had a profound impact on patient care.

Michael J. Morris, MD on the Impact of PyL-PET/CT Scans on the Clinical Management of Patients With Prostate Cancer

Dr. Morris discusses results and implications of the CHAARTED trial, which studied the survival impact of androgen deprivation therapy (ADT) plus docetaxel vs ADT alone for hormone-sensitive newly metastatic prostate cancer.

Author | Michael J. Morris, MD

Articles

New content coming soon, please check back later.